Skip to main content
SpringerLink
Log in

HIV-Related Peripheral Nervous System Illness

  • Chapter
  • First Online:
Global Virology II - HIV and NeuroAIDS

  • 803 Accesses

Abstract

As HIV has been transformed into a chronic disease by the use of combination antiretroviral therapy (CART), focus has shifted toward management of the chronic complications of HIV-infected individuals. These include a variety of disorders of the peripheral nervous system, which are addressed in this chapter. Among these disorders, distal symmetric polyneuropathy (DSP) is the most common and typically presents with uncomfortable sensory symptoms in the feet. Given the lack of neuroregenerative treatment for DSP, therapy focuses on control of painful symptoms with agents such as antiepileptics and antidepressants. DSP may predispose HIV-infected patients to other forms of neuropathy. These include autonomic neuropathy, the symptoms of which vary depending on the organ systems involved, and mononeuropathies such as carpal tunnel syndrome. In addition to these common peripheral nerve disorders, which are thought to be mechanistically linked to HIV, we also discuss other disorders that are common in the HIV-infected population perhaps due to accentuated aging, such as radiculopathy due to degenerative spine disease. Finally, we address rare neuromuscular conditions that have been reported in HIV-infected patients including the demyelinating neuropathies, mononeuropathy multiplex, the diffuse infiltrative lymphocytosis syndrome, amyotrophic lateral sclerosis, and myopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ellis RJ, Rosario D, Clifford DB et al (2010) Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER study. Arch Neurol 67(5):552–558

    Article  PubMed  PubMed Central  Google Scholar 

  2. Robinson-Papp J, Sharma S, Simpson DM, Morgello S (2013) Autonomic dysfunction is common in HIV and associated with distal symmetric polyneuropathy. J Neurovirol 19(2):172–180

    Article  PubMed  PubMed Central  Google Scholar 

  3. Morgello S, Estanislao L, Simpson D et al (2004) HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the manhattan HIV brain bank. Arch Neurol 61(4):546–551

    Article  PubMed  Google Scholar 

  4. England JD, Gronseth GS, Franklin G et al (2009) Practice parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the american academy of neurology, american association of neuromuscular and electrodiagnostic medicine, and american academy of physical medicine and rehabilitation. Neurology 72(2):177–184

    Article  CAS  PubMed  Google Scholar 

  5. Morrison B, Chaudhry V (2012) Medication, toxic, and vitamin-related neuropathies. Continuum (Minneap Minn) 18(1):139–160

    Google Scholar 

  6. Simpson DM, Tagliati M (1995) Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 9(2):153–161

    CAS  PubMed  Google Scholar 

  7. Gardner K, Hall PA, Chinnery PF, Payne BA (2014) HIV treatment and associated mitochondrial pathology: review of 25 years of in vitro, animal, and human studies. Toxicol Pathol 42(5):811–822

    Article  PubMed  Google Scholar 

  8. Zhou L, Kitch DW, Evans SR et al (2007) Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy. Neurology 68(24):2113–2119

    Article  CAS  PubMed  Google Scholar 

  9. Cornblath DR, Chaudhry V, Carter K et al (1999) Total neuropathy score: validation and reliability study. Neurology 53(8):1660–1664

    Article  CAS  PubMed  Google Scholar 

  10. Simpson DM, Kitch D, Evans SR et al (2006) HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology 66(11):1679–1687

    Article  CAS  PubMed  Google Scholar 

  11. Robinson-Papp J, Sharma S, Dhadwal N, Simpson DM, Morgello S (2015) Optimizing measures of HIV-associated neuropathy. Muscle Nerve 51(1):56–64

    Article  PubMed  Google Scholar 

  12. Cherry CL, Wesselingh SL, Lal L, McArthur JC (2005) Evaluation of a clinical screening tool for HIV-associated sensory neuropathies. Neurology 65(11):1778–1781

    Article  PubMed  Google Scholar 

  13. Evans SR, Ellis RJ, Chen H et al (2011) Peripheral neuropathy in HIV: prevalence and risk factors. AIDS 25(7):919–928

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lichtenstein KA, Armon C, Baron A et al (2005) Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis 40(1):148–157

    Article  PubMed  Google Scholar 

  15. Robinson-Papp J, Gelman BB, Grant I et al (2012) Substance abuse increases the risk of neuropathy in an HIV-infected cohort. Muscle Nerve 45(4):471–476

    Article  PubMed  PubMed Central  Google Scholar 

  16. Malvar J, Vaida F, Sanders CF et al (2015) Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy. Pain 156(4):731–739

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Keswani SC, Polley M, Pardo CA, Griffin JW, McArthur JC, Hoke A (2003) Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol 54(3):287–296

    Article  CAS  PubMed  Google Scholar 

  18. Acharjee S, Noorbakhsh F, Stemkowski PL et al (2010) HIV-1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain. FASEB J 24(11):4343–4353

    Article  CAS  PubMed  Google Scholar 

  19. Lehmann HC, Chen W, Borzan J, Mankowski JL, Hoke A (2011) Mitochondrial dysfunction in distal axons contributes to human immunodeficiency virus sensory neuropathy. Ann Neurol 69(1):100–110

    Article  CAS  PubMed  Google Scholar 

  20. Dworkin RH, McDermott MP (2014) Back to the future: the need to resolve analgesic efficacy in human immunodeficiency virus neuropathy. Pain 155(10):1913–1915

    Article  PubMed  Google Scholar 

  21. Simpson DM, Rice AS, Emir B et al (2014) A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy. Pain 155(10):1943–1954

    Article  CAS  PubMed  Google Scholar 

  22. Simpson DM, Brown S, Tobias JK, Vanhove GF (2014) NGX-4010 C107 study group. NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study. Clin J Pain 30(2):134–142

    PubMed  Google Scholar 

  23. Dorfman D, George MC, Schnur J, Simpson DM, Davidson G, Montgomery G (2013) Hypnosis for treatment of HIV neuropathic pain: a preliminary report. Pain Med 14(7):1048–1056

    Article  PubMed  Google Scholar 

  24. George MC, Wongmek A, Kaku M, Nmashie A, Robinson-Papp J (2015) A mixed-methods pilot study of mindfulness based stress reduction for HIV-associated chronic pain. Behav Med:1–12

    Google Scholar 

  25. Ellis RJ, Toperoff W, Vaida F et al (2009) Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology 34(3):672–680

    Article  CAS  PubMed  Google Scholar 

  26. Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W (2012) COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc 87(12):1196–1201

    Article  PubMed  PubMed Central  Google Scholar 

  27. Low PA, Benarroch EE (2008) Laboratory evaluation of autonomic failure. In: Clinical autonomic disorders, 3rd edn. Wolters Kluwer, Lippincott Williams & Williams, Philadelphia, p 130

    Google Scholar 

  28. Novak P (2011) Quantitative autonomic testing. J Vis Exp (53). pii: 2502. doi:10.3791/2502

  29. Craddock C, Pasvol G, Bull R, Protheroe A, Hopkin J (1987) Cardiorespiratory arrest and autonomic neuropathy in AIDS. Lancet 2(8549):16–18

    Article  CAS  PubMed  Google Scholar 

  30. Freeman R, Roberts MS, Friedman LS, Broadbridge C (1990) Autonomic function and human immunodeficiency virus infection. Neurology 40(4):575–580

    Article  CAS  PubMed  Google Scholar 

  31. Cohen JA, Laudenslager M (1989) Autonomic nervous system involvement in patients with human immunodeficiency virus infection. Neurology 39(8):1111–1112

    Article  CAS  PubMed  Google Scholar 

  32. Ruttimann S, Hilti P, Spinas GA, Dubach UC (1991) High frequency of human immunodeficiency virus-associated autonomic neuropathy and more severe involvement in advanced stages of human immunodeficiency virus disease. Arch Intern Med 151(12):2441–2443

    Article  CAS  PubMed  Google Scholar 

  33. Villa A, Foresti V, Confalonieri F (1992) Autonomic nervous system dysfunction associated with HIV infection in intravenous heroin users. AIDS 6(1):85–89

    Article  CAS  PubMed  Google Scholar 

  34. Villa A, Foresti V, Confalonieri F (1995) Autonomic neuropathy and prolongation of QT interval in human immunodeficiency virus infection. Clin Auton Res 5(1):48–52

    Article  CAS  PubMed  Google Scholar 

  35. Rogstad KE, Shah R, Tesfaladet G, Abdullah M, Ahmed-Jushuf I (1999) Cardiovascular autonomic neuropathy in HIV infected patients. Sex Transm Infect 75(4):264–267

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Becker K, Gorlach I, Frieling T, Haussinger D (1997) Characterization and natural course of cardiac autonomic nervous dysfunction in HIV-infected patients. AIDS 11(6):751–757

    Article  CAS  PubMed  Google Scholar 

  37. Neild PJ, Amadi A, Ponikowski P, Coats AJ, Gazzard BG (2000) Cardiac autonomic dysfunction in AIDS is not secondary to heart failure. Int J Cardiol 74(2–3):133–137

    Article  CAS  PubMed  Google Scholar 

  38. Robinson-Papp J, Sharma SK (2013) Autonomic neuropathy in HIV is unrecognized and associated with medical morbidity. AIDS Patient Care STDs 27(10):539–543

    Article  PubMed  PubMed Central  Google Scholar 

  39. Sloan EK, Nguyen CT, Cox BF, Tarara RP, Capitanio JP, Cole SW (2008) SIV infection decreases sympathetic innervation of primate lymph nodes: the role of neurotrophins. Brain Behav Immun 22(2):185–194

    Article  CAS  PubMed  Google Scholar 

  40. Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE (2008) The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 168(5):508–513

    Article  PubMed  Google Scholar 

  41. Belec L, Gherardi R, Georges AJ et al (1989) Peripheral facial paralysis and HIV infection: report of four african cases and review of the literature. J Neurol 236(7):411–414

    Article  CAS  PubMed  Google Scholar 

  42. Sullivan FM, Swan IR, Donnan PT et al (2007) Early treatment with prednisolone or acyclovir in bell’s palsy. N Engl J Med 357(16):1598–1607

    Article  CAS  PubMed  Google Scholar 

  43. Serrano P, Hernandez N, Arroyo JA, de Llobet JM, Domingo P (2007) Bilateral bell palsy and acute HIV type 1 infection: report of 2 cases and review. Clin Infect Dis 44(6):e57–e61

    Article  PubMed  Google Scholar 

  44. Halperin JJ (2003) Lyme disease and the peripheral nervous system. Muscle Nerve 28(2):133–143

    Article  PubMed  Google Scholar 

  45. Uscategui T, Doree C, Chamberlain IJ, Burton MJ (2008) Antiviral therapy for ramsay hunt syndrome (herpes zoster oticus with facial palsy) in adults. Cochrane Database Syst Rev (4):CD006851

    Google Scholar 

  46. Keane JR (1994) Bilateral seventh nerve palsy: analysis of 43 cases and review of the literature. Neurology 44(7):1198–1202

    Article  CAS  PubMed  Google Scholar 

  47. Gherardi R, Lebargy F, Gaulard P, Mhiri C, Bernaudin JF, Gray F (1989) Necrotizing vasculitis and HIV replication in peripheral nerves. N Engl J Med 321(10):685–686

    CAS  PubMed  Google Scholar 

  48. Gherardi R, Belec L, Mhiri C et al (1993) The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation. Arthritis Rheum 36(8):1164–1174

    Article  CAS  PubMed  Google Scholar 

  49. Lipkin WI, Parry G, Kiprov D, Abrams D (1985) Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology 35(10):1479–1483

    Article  CAS  PubMed  Google Scholar 

  50. So YT, Holtzman DM, Abrams DI, Olney RK (1988) Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey. Arch Neurol 45(9):945–948

    Article  CAS  PubMed  Google Scholar 

  51. Miller RG, Parry GJ, Pfaeffl W, Lang W, Lippert R, Kiprov D (1988) The spectrum of peripheral neuropathy associated with ARC and AIDS. Muscle Nerve 11(8):857–863

    Article  CAS  PubMed  Google Scholar 

  52. Said G, Lacroix C, Chemouilli P et al (1991) Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 29(2):139–146

    Article  CAS  PubMed  Google Scholar 

  53. Roullet E, Assuerus V, Gozlan J et al (1994) Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive cases. Neurology 44(11):2174–2182

    Article  CAS  PubMed  Google Scholar 

  54. Acharya JN, Pacheco VH (2008) Neurologic complications of hepatitis C. Neurologist 14(3):151–156

    Article  PubMed  Google Scholar 

  55. Cornblath DR, McArthur JC, Kennedy PG, Witte AS, Griffin JW (1987) Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol 21(1):32–40

    Article  CAS  PubMed  Google Scholar 

  56. Brannagan TH 3rd, Zhou Y (2003) HIV-associated guillain-barre syndrome. J Neurol Sci 208(1–2):39–42

    Article  PubMed  Google Scholar 

  57. van der Meche FG, Schmitz PI (1992) A randomized trial comparing intravenous immune globulin and plasma exchange in guillain-barre syndrome. Dutch guillain-barre study group. N Engl J Med 326(17):1123–1129

    Article  PubMed  Google Scholar 

  58. Hughes R, Bensa S, Willison H et al (2001) Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50(2):195–201

    Article  CAS  PubMed  Google Scholar 

  59. Molony E, Westfall AO, Perry BA et al (2014) Low back pain and associated imaging findings among HIV-infected patients referred to an HIV/palliative care clinic. Pain Med 15(3):418–424

    Article  PubMed  Google Scholar 

  60. Jiao JM, So E, Jebakumar J, George MC, Simpson DM, Robinson-Papp J (2016) Chronic pain disorders in HIV primary care: clinical characteristics and association with healthcare utilization. Pain 157(4):931–937

    Article  PubMed  Google Scholar 

  61. Bhatia R, Ryscavage P, Taiwo B (2012) Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy. J Neurovirol 18(4):247–255

    Article  CAS  PubMed  Google Scholar 

  62. Miller RF, Fox JD, Thomas P et al (1996) Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients. J Neurol Neurosurg Psychiatry 61(5):456–460

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Lanska MJ, Lanska DJ, Schmidley JW (1988) Syphilitic polyradiculopathy in an HIV-positive man. Neurology 38(8):1297–1301

    Article  CAS  PubMed  Google Scholar 

  64. Leger JM, Henin D, Belec L et al (1992) Lymphoma-induced polyradiculopathy in AIDS: two cases. J Neurol 239(3):132–134

    Article  CAS  PubMed  Google Scholar 

  65. Robinson-Papp J, Simpson DM (2009) Neuromuscular diseases associated with HIV-1 infection. Muscle Nerve 40(6):1043–1053

    Article  PubMed  PubMed Central  Google Scholar 

  66. Chahin N, Temesgen Z, Kurtin PJ, Spinner RJ, Dyck PJ (2010) HIV lumbosacral radiculoplexus neuropathy mimicking lymphoma: diffuse infiltrative lymphocytosis syndrome (DILS) restricted to nerve? Muscle Nerve 41(2):276–282

    PubMed  PubMed Central  Google Scholar 

  67. Chen-Plotkin AS, Christopoulos KA, Venna N (2007) Demyelinating polyneuropathy and herpes simplex lumbosacral radiculitis in a patient with chronic HIV infection. AIDS 21(12):1663–1664

    Article  PubMed  Google Scholar 

  68. Masjuan J, Corral I, Fernandez-Ruiz LC (1997) Mycobacterial acute lumbosacral polyradiculopathy as the initial manifestation of AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 15(2):175

    Article  CAS  PubMed  Google Scholar 

  69. Hernandez-Albujar S, Arribas JR, Royo A, Gonzalez-Garcia JJ, Pena JM, Vazquez JJ (2000) Tuberculous radiculomyelitis complicating tuberculous meningitis: case report and review. Clin Infect Dis 30(6):915–921

    Article  CAS  PubMed  Google Scholar 

  70. Brooks BR (1994) El escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis. subcommittee on motor neuron diseases/amyotrophic lateral sclerosis of the world federation of neurology research group on neuromuscular diseases and the el escorial “clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci 24 Suppl:96–107.

    Google Scholar 

  71. Alfahad T, Nath A (2013) Retroviruses and amyotrophic lateral sclerosis. Antivir Res 99(2):180–187

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Verma A, Berger JR (2006) ALS syndrome in patients with HIV-1 infection. J Neurol Sci 240(1–2):59–64

    Article  CAS  PubMed  Google Scholar 

  73. Moulignier A, Moulonguet A, Pialoux G, Rozenbaum W (2001) Reversible ALS-like disorder in HIV infection. Neurology 57(6):995–1001

    Article  CAS  PubMed  Google Scholar 

  74. Jubelt B (1992) Motor neuron diseases and viruses: poliovirus, retroviruses, and lymphomas. Curr Opin Neurol Neurosurg 5(5):655–658

    CAS  PubMed  Google Scholar 

  75. Viola MV, Frazier M, White L, Brody J, Spiegelman S (1975) RNA-instructed DNA polymerase activity in a cytoplasmic particulate fraction in brains from guamanian patients. J Exp Med 142(2):483–494

    Article  CAS  PubMed  Google Scholar 

  76. Li W, Lee MH, Henderson L et al (2015) Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl Med 7(307):307ra153

    Article  PubMed  Google Scholar 

  77. Racaniello VR (2006) One hundred years of poliovirus pathogenesis. Virology 344(1):9–16

    Article  CAS  PubMed  Google Scholar 

  78. Ince P, Clark B, Holton J, Revesz T, Wharton S (2008) Diseases of movement and system degenerations. In: Love S, Louis D, Ellison D (eds) Greenfield’s neuropathology, 8th edn. Taylor & Francis Group, Boca Raton, pp 949–953

    Google Scholar 

  79. Ghrenassia E, Martis N, Boyer J, Burel-Vandenbos F, Mekinian A, Coppo P (2015) The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive review. J Autoimmun 59:19–25

    Article  CAS  PubMed  Google Scholar 

  80. Moulignier A, Authier FJ, Baudrimont M et al (1997) Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol 41(4):438–445

    Article  CAS  PubMed  Google Scholar 

  81. Manfredi R, Motta R, Patrono D, Calza L, Chiodo F, Boni P (2002) A prospective case-control survey of laboratory markers of skeletal muscle damage during HIV disease and antiretroviral therapy. AIDS 16(14):1969–1971

    Article  PubMed  Google Scholar 

  82. HIV Neuromuscular Syndrome Study Group (2004) HIV-associated neuromuscular weakness syndrome. AIDS 18(10):1403–1412

    Article  Google Scholar 

  83. Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, Schon EA (1991) Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 337(8740):508–510

    Article  CAS  PubMed  Google Scholar 

  84. Simpson DM, Citak KA, Godfrey E, Godbold J, Wolfe DE (1993) Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished? Neurology 43(5):971–976

    Article  CAS  PubMed  Google Scholar 

  85. Simpson DM, Bender AN (1988) Human immunodeficiency virus-associated myopathy: analysis of 11 patients. Ann Neurol 24(1):79–84

    Article  CAS  PubMed  Google Scholar 

  86. Johnson RW, Williams FM, Kazi S, Dimachkie MM, Reveille JD (2003) Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. Arthritis Rheum 49(2):172–178

    Article  PubMed  Google Scholar 

  87. Heckmann JM, Pillay K, Hearn AP, Kenyon C (2010) Polymyositis in african HIV-infected subjects. Neuromuscul Disord 20(11):735–739

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Icahn School of Medicine at Mount Sinai, One Gustave L Levy Place, Box 1052, New York, NY, 10029, USA

    Jocelyn Jiao, David M. Simpson & Jessica Robinson-Papp MD, MS

Authors
  1. Jocelyn Jiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David M. Simpson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jessica Robinson-Papp MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jessica Robinson-Papp MD, MS .

Editor information

Editors and Affiliations

  1. Department of Internal Medicine, Division of Infectious Diseases and International Health, University of South Florida, Tampa, Florida, USA

    Paul Shapshak

  2. Department of Neurology, UCLA David Geffen School of Medicine, Los Angeles, California, USA

    Andrew J. Levine

  3. Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA

    Brian T. Foley

  4. Department of Internal Medicine, Division of Infectious Diseases and International Health, University of South Florida, Morsani College of Medicine, Tampa, Florida, USA

    Charurut Somboonwit

  5. Department of Neurology, UCLA David Geffen School of Medicine, Los Angeles, California, USA

    Elyse Singer

  6. Department of Oral Biology and Medicine, UCLA School of Dentistry, Los Angeles, California, USA

    Francesco Chiappelli

  7. Department of Internal Medicine, Division of Infectious Diseases and International Health, University of South Florida, Morsani College of Medicine, Tampa, Florida, USA

    John T. Sinnott

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this chapter

Cite this chapter

Jiao, J., Simpson, D.M., Robinson-Papp, J. (2017). HIV-Related Peripheral Nervous System Illness. In: Shapshak, P., et al. Global Virology II - HIV and NeuroAIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7290-6_9

Download citation

Publish with us

Policies and ethics

Search

Navigation